EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Progression‐associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesis

Jacqueline Fontugne iD, Jennifer Wong, Luc Cabel, Hélène Neyret-Kahn, Narjesse Karboul, Pascale Maillé, Audrey Rapinat, David Gentien, André Nicolas, Sylvain Baulande, Mathilde Sibony, Isabelle Bernard-Pierrot und 2 weitere

The Journal of Pathology · 2023

DOI: 10.1002/path.6060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology, 2023. Verfasst von Jacqueline Fontugne und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institut Curie, CNRS, UMR144, Equipe labellisée Ligue Contre le Cancer, PSL Research University, Paris, France. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Sarcoma, Soft Tissue Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Marie Curie, Fondation ARC pour la Recherche sur le Cancer, Institut Curie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aggressive basal/squamous (Ba/Sq) bladder cancer (BLCA) subtype is often diagnosed at the muscle‐invasive stage and can progress to the sarcomatoid variant. Identification of molecular changes occurring during progression from non‐muscle‐invasive BLCA (NMIBC) to Ba/Sq muscle‐invasive BLCA (MIBC) is thus challenging in human disease. We used the N ‐butyl‐ N ‐(4‐hydroxybutyl)‐nitrosamine (BBN) mouse model of Ba/Sq MIBC to study longitudinally the molecular changes leading to the Ba/Sq phenotype and to the sarcomatoid variant using IHC and microdissection followed by RNA‐seq at all stages of progression. A shift to the Ba/Sq phenotype started in early progression stages. Pathway analysis of gene clusters with coordinated expression changes revealed Shh signaling loss and a shift from fatty acid metabolism to glycolysis. An upregulated cluster, appearing early in carcinogenesis, showed relevance to human disease, identifying NMIBC patients at risk of progression. Similar to the human counterpart, sarcomatoid BBN tumors displayed a Ba/Sq phenotype and epithelial–mesenchymal transition (EMT) features. An EGFR/FGFR1 signaling switch occurred with sarcomatoid dedifferentiation and correlated with EMT. BLCA cell lines with high EMT were the most sensitive to FGFR1 knockout and resistant to EGFR knockout. Taken together, these findings provide insights into the underlying biology of Ba/Sq BLCA progression and sarcomatoid dedifferentiation with potential clinical implications. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsSarcomaSoft Tissue NeoplasmsCarcinoma, Squamous CellAnimalsMiceHumansUrinary BladderCarcinogenesisErbB Receptors

Stichwörter der Autor:innen

BBN mouse modelEGFRFGFR1carcinogenesisimmunohistochemistrymolecular evolution of bladder cancersarcomatoid varianturothelial carcinoma

Substanzen

ErbB Receptors

Autor:innen und Institutionen

  • Institut Curie, CNRS, UMR144, Equipe labellisée Ligue Contre le Cancer, PSL Research University, Paris, France.
  • Department of Pathology, Institut Curie, Saint-Cloud, France.
  • Université Paris-Saclay, Université Versailles St-Quentin, Montigny-le-Bretonneux, France.
  • Department of Genetics, Institut Curie, Paris, France.
  • Genomics Core Facility, Translational Research Department, PSL Research University, Institut Curie, Paris, France.
  • Department of Pathology, Institut Curie, Paris, France.

ORCID-Profile: Jacqueline Fontugne, Yves Allory

Förderung

  • Marie Curie
  • Fondation ARC pour la Recherche sur le Cancer
  • Institut Curie
  • Agence Nationale de la Recherche

Zitieren

APA

Fontugne, J., Wong, J., Cabel, L., Neyret-Kahn, H., Karboul, N., Maillé, P., Rapinat, A., Gentien, D., Nicolas, A., Baulande, S., Sibony, M., Bernard-Pierrot, I., Radvanyi, F., & Allory, Y. (2023). Progression‐associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesis. The Journal of Pathology. https://doi.org/10.1002/path.6060

Vancouver

Fontugne J, Wong J, Cabel L, Neyret-Kahn H, Karboul N, Maillé P, et al. Progression‐associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesis. The Journal of Pathology. 2023. doi:10.1002/path.6060

BibTeX
@article{Fontugne2023,
  author = {Fontugne, Jacqueline and Wong, Jennifer and Cabel, Luc and Neyret-Kahn, Hélène and Karboul, Narjesse and Maillé, Pascale and Rapinat, Audrey and Gentien, David and Nicolas, André and Baulande, Sylvain and Sibony, Mathilde and Bernard-Pierrot, Isabelle and Radvanyi, François and Allory, Yves},
  title = {Progression‐associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesis},
  journal = {The Journal of Pathology},
  year = {2023},
  doi = {10.1002/path.6060}
}
Kostenlos starten →